close

Register today to unlock Valuecruncher and get unlimited access

  • Get unlimited access to all compartors and data
  • Save and share valuations as well as comment on others
  • Alter and save your favourite comparator companies

Already registered? Please login now

Comparison Analysis  

What's this?
Dollar184036Point69
Implied share price

Buy Undervalued by 235090.7%

5% margin of safety What's this?

EV / Revenue
Use Average
ABII
Abraxis Bioscience, Inc.
KUN
China Shenghuo Pharmaceutical Hldg, Inc.
Change
GILD
Gilead Sciences, Inc.
Change
SNY
Sanofi SA (ADR)
Change
AMGN
Amgen, Inc.
Change
20740.73 8.25 27840.41 6.6 2.18 6.38
All amounts in millions
from last financial year
         
Implied Share Price $184036.69 $46540.54 $351274.12 $540065.89 $547290.10
Market Cap 3,166 1,229,412 161,906 134,674 124,358
Net Debt -203 20 2,276 7,255 3,689
Enterprise Value (EV) 2,963 1,229,432 164,182 74,387 128,047
Revenue 359 44 24,890 34,109 20,063
Balance Sheet          
Total Assets 1,068 58 34,664 97,392 69,009
Total Liabilities 225 56 19,238 41,272 43,231
Shareholders Equity 842 2 15,426 56,120 25,778.0

Where are the EBIT and EBITDA figures?

Certain companies and those in specific industries (for example insurance) do not report financial results at the EBIT or EBITDA line. For these companies where Valuecruncher does not have EBIT or EBITDA numbers we exclude the valuation metrics driven by these figures. Valuecruncher makes our other valuation metrics available for these companies.

To learn more about comparison analysis, please read our guide to comparison analysis

Comments

No comments yet. Login to comment.